Assignee
CUMBERLAND PHARMACEUTICALS INC
US·21 granted patents·44 pending applications·91 citations·filing 2001–2025
Top patents by PatentIndex Score
65 records- 0194US8952065B2Acetylcysteine composition and uses thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Feb 10, 2015·16 cites·9 claims
- 0294US8653061B2Acetylcysteine composition and uses thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2013·Granted Feb 18, 2014·17 cites·10 claims
- 0391US9327028B2Acetylcysteine compositions and methods of use thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·12 cites·11 claims
- 0491US6727286B2Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acidCUMBERLAND PHARMACEUTICALS INC·Filed 2001·Granted Apr 27, 2004·31 cites·44 claims
- 0590US11806400B2Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Nov 7, 2023·2 cites·16 claims
- 0688US2025114334A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0785US9693998B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·4 cites·20 claims
- 0884US2024024481A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0984US2023381147A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1082US9114068B2Treating patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Aug 25, 2015·2 cites·14 claims
- 1178US12161632B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·0 cites·10 claims
- 1278US11571412B2Thromboxane receptor antagonists in AERD/asthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Feb 7, 2023·0 cites·4 claims
- 1378US10314824B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·1 cites·9 claims
- 1478US10064845B2Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Sep 4, 2018·2 cites·22 claims
- 1577US2022133696A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1677US2020121793A1Acetylcysteine Compositions and Methods of use ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1776US9931311B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Apr 3, 2018·1 cites·7 claims
- 1876US2025049764A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1976US2022211674A1Thromboxane Receptor Antagonists in AERD/AsthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2076US2022218672A1Thromboxane Receptor Antagonists in AERD/AsthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2174US8933115B2Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2013·Granted Jan 13, 2015·1 cites·27 claims
- 2274US2020375953A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2373US9649284B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted May 16, 2017·1 cites·19 claims
- 2473US9138404B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·1 cites·20 claims
- 2573US2021137895A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2673US2025235539A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2773US2021106561A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2872US10925860B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Feb 23, 2021·0 cites·7 claims
- 2972US2020316022A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3071US2021015798A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3171US2020171007A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3270US2020253935A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3369US10583126B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Mar 10, 2020·0 cites·7 claims
- 3469US2019343810A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3568US2019247365A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3668US2020113872A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3768US2019269778A1Acetylcysteine Compositions and Methods of use ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3867US9820966B2Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Nov 21, 2017·0 cites·28 claims
- 3967US2019343809A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4066US2019117621A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4165US2018344693A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4265US2019117628A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4365US2018055801A1Acetylcysteine Composition and Uses ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4464US10016399B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Jul 10, 2018·0 cites·19 claims
- 4564US2018055936A1Acetylcysteine Compositions and Methods of use ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4664US2019142944A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4763US10456380B2Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Oct 29, 2019·0 cites·20 claims
- 4863US2018036282A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4963US2019151291A1Ifetroban treatment of portal hypertensionCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 5062US2017042850A1Acetylcysteine Composition and Uses ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →